Inogen Company Leadership

INGN Stock  USD 6.90  0.20  2.99%   
Inogen's insiders are aggressively selling. The analysis of insiders' sentiment of trading Inogen Inc stock suggests that virtually all insiders are panicking at this time. Inogen employs about 834 people. The company is managed by 27 executives with a total tenure of roughly 121 years, averaging almost 4.0 years of service per executive, having 30.89 employees per reported executive.
Raymond Huggenberger  CEO
CEO and Director
Heath Lukatch  Chairman
Independent Chairman of the Board

Inogen's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2022-03-03Ray Benjamin M AndersonDisposed 4516 @ 34.68View
2021-08-16Raymond HuggenbergerDisposed 6594 @ 62.69View
2021-08-02Alison BauerleinDisposed 1397 @ 80.33View
2021-07-30Alison BauerleinDisposed 8235 @ 80.01View
2021-07-27Brenton TaylorDisposed 7942 @ 75.02View
2021-07-15Raymond HuggenbergerDisposed 7000 @ 65.83View
2021-06-15Raymond HuggenbergerDisposed 7087 @ 63.81View
2021-06-02Holdings A/S NovoDisposed 680000 @ 57.32View
Monitoring Inogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Inogen's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Inogen's future performance. Based on our forecasts, it is anticipated that Inogen will maintain a workforce of about 830 employees by May 2024.
 
Yuan Drop
 
Covid

Inogen's latest congressional trading

Congressional trading in companies like Inogen Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Inogen by those in governmental positions are based on the same information available to the general public.
2018-11-20Representative Lamar SmithAcquired Under $15KVerify

Inogen Management Team Effectiveness

The company has return on total asset (ROA) of (0.1091) % which means that it has lost $0.1091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.408) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to -0.35. In addition to that, Return On Capital Employed is likely to grow to -0.24. At this time, Inogen's Deferred Long Term Asset Charges is very stable compared to the past year. As of the 23rd of April 2024, Intangibles To Total Assets is likely to grow to 0.14, while Total Assets are likely to drop about 292 M.
As of the 23rd of April 2024, Common Stock Shares Outstanding is likely to drop to about 22.7 M. In addition to that, Net Loss is likely to grow to about (71.6 M)

Inogen Workforce Comparison

Inogen Inc is rated fifth overall in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 7,724. Inogen retains roughly 834 in number of employees claiming about 11% of equities under Health Care industry.

Inogen Profit Margins

The company has Profit Margin (PM) of (0.32) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.530.4326
Fairly Up
Slightly volatile

Inogen Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Inogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.75
6
8
 247,053 
 33,263 
2023-12-01
0.3333
2
6
 5,131 
 92,748 
2023-09-01
0.4286
3
7
 5,032 
 7,655 
2023-06-01
1.2222
11
9
 110,431 
 9,274 
2023-03-01
0.6667
16
24
 225,500 
 71,663 
2022-12-01
0.3846
5
13
 10,450 
 15,712 
2022-09-01
0.1111
1
9
 3,075 
 11,150 
2022-06-01
2.0
12
6
 266,750 
 10,998 
2022-03-01
1.5
12
8
 141,722 
 45,220 
2021-12-01
0.5
2
4
 819.00 
 1,534 
2021-09-01
0.5714
16
28
 81,611 
 110,076 
2021-06-01
0.8214
23
28
 62,654 
 727,685 
2021-03-01
0.5882
30
51
 297,778 
 1,156,284 
2020-12-01
0.1818
4
22
 17,910 
 36,550 
2020-09-01
0.2143
3
14
 22,115 
 1,739 
2020-06-01
0.5714
8
14
 27,746 
 1,731 
2020-03-01
0.5
7
14
 44,190 
 3,751 
2019-12-01
0.2222
2
9
 504.00 
 1,244 
2019-09-01
0.6
6
10
 7,506 
 5,110 
2019-06-01
1.875
15
8
 32,776 
 1,104 
2019-03-01
0.8571
24
28
 52,212 
 25,009 
2018-12-01
0.3818
21
55
 89,426 
 129,644 
2018-09-01
0.2748
36
131
 111,159 
 234,816 
2018-06-01
0.44
22
50
 54,888 
 107,054 
2018-03-01
0.4405
37
84
 178,405 
 336,966 
2017-12-01
0.4792
23
48
 97,333 
 209,713 
2017-09-01
0.6944
25
36
 90,832 
 138,667 
2017-06-01
0.5714
24
42
 169,277 
 190,560 
2017-03-01
0.3171
13
41
 103,057 
 233,940 
2016-12-01
0.4167
10
24
 60,050 
 122,729 
2016-09-01
0.4
12
30
 92,485 
 197,970 
2016-06-01
0.9583
23
24
 575,067 
 241,916 
2016-03-01
0.4444
8
18
 69,150 
 86,364 
2015-12-01
0.4848
16
33
 231,473 
 313,778 
2015-09-01
0.42
21
50
 206,646 
 406,414 
2015-06-01
0.1818
6
33
 387,500 
 741,534 
2015-03-01
0.5079
32
63
 601,001 
 2,992,244 
2014-12-01
0.7821
122
156
 1,440,695 
 8,519,837 
2014-09-01
0.087
10
115
 101,295 
 1,190,593 
2014-06-01
2.7143
19
7
 575,021 
 50,544 
2014-03-01
0.4578
38
83
 22,529,043 
 18,868,060 
2008-06-01
2.0
4
2
 705,000 
 74,000 
2007-03-01
1.0
2
2
 102,400 
 83,200 
2003-09-01
5.0
5
1
 112,350 
 5,500 

Inogen Notable Stakeholders

An Inogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inogen often face trade-offs trying to please all of them. Inogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Brenton TaylorCo-Founder and Executive VP of EngineeringProfile
Alison BauerleinCo-Founder, CFO, Principal Accounting Officer, Executive VP of Fin., Treasurer and SecretaryProfile
Byron MyersCo-Founder and VP of MarketingProfile
Kevin SmithCEO PresidentProfile
Raymond HuggenbergerCEO and DirectorProfile
Heath LukatchIndependent Chairman of the BoardProfile
Bart SanfordExecutive Vice President OperationsProfile
Matthew ScribnerExecutive Vice President - OperationsProfile
Michael SergesketterChief PresidentProfile
Michael BourqueCFO VPProfile
Scott WilkinsonPres and COOProfile
Scott BeardsleyDirectorProfile
Scott GreerIndependent DirectorProfile
Benjamin AndersonRayIndependent DirectorProfile
Heather RiderDirectorProfile
Loren McFarlandIndependent DirectorProfile
Jason SomerGeneral VPProfile
Agnes LeeVP PlanningProfile
Philip CorrinSenior ChainProfile
Jennifer BoyerExecutive OfficerProfile
MBA MDExecutive OfficerProfile
Kristin CaltriderCFO VPProfile
Nabil ShabshabPres CEOProfile
Vijay PaliwalSenior EnablementProfile
George ParrEx OfficerProfile
Matthew PigeonInvestor OfficerProfile
Grgoire RamadeExecutive OfficerProfile

About Inogen Management Performance

The success or failure of an entity such as Inogen Inc often depends on how effective the management is. Inogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.36)(0.35)
Return On Capital Employed(0.25)(0.24)
Return On Assets(0.31)(0.30)
Return On Equity(0.50)(0.48)
The data published in Inogen's official financial statements usually reflect Inogen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inogen Inc. For example, before you start analyzing numbers published by Inogen accountants, it's critical to develop an understanding of what Inogen's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Inogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inogen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inogen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inogen Inc. Please utilize our Beneish M Score to check the likelihood of Inogen's management manipulating its earnings.

Inogen Workforce Analysis

Traditionally, organizations such as Inogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inogen within its industry.

Inogen Manpower Efficiency

Return on Inogen Manpower

Revenue Per Employee378.5K
Revenue Per Executive11.7M
Net Loss Per Employee122.8K
Net Loss Per Executive3.8M
Working Capital Per Employee161.4K
Working Capital Per Executive5M
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Inogen Inc information on this page should be used as a complementary analysis to other Inogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Inogen Stock analysis

When running Inogen's price analysis, check to measure Inogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inogen is operating at the current time. Most of Inogen's value examination focuses on studying past and present price action to predict the probability of Inogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inogen's price. Additionally, you may evaluate how the addition of Inogen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Inogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.873
Earnings Share
(4.42)
Revenue Per Share
13.62
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.11)
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.